In a decisive move, the American Clinical Laboratory Association (ACLA) is attempting to rally the lab community and stakeholders across the nation while taking on Congress by creating a new campaign called the “Stop Lab Cuts campaign.” The campaign is an effort to safeguard patient access to laboratory services through an advocacy effort to pass the Saving Access to Laboratory Services Act (S. 4449/H.R. 8188) by the end of the year. With proposed policies over the years aiming to strike and weaken reimbursement, staffing levels impacted by the great resignation, and the general financial turmoil created by a global pandemic, the value of protecting dwindling reimbursement is imperative.
As you may know, Medicare payment cuts are likely coming at the start of next year. By cutting reimbursement, access to diagnostic tests could be put at risk. However, according to the ACLA, there are even more consequences at stake stating “After three prior rounds of 10 percent cuts, additional reductions to payments may result in a weakened clinical lab infrastructure, making it more difficult to deliver routine health care and respond to the next public health crisis. Without strong clinical laboratories, the nation’s response to COVID-19 would have been severely hampered.”
According to the ACLA, over 800 tests across the nation are slated to experience an up to 15 percent reimbursement cut at the start of the next year. However, this is the shadow of “previous rounds of cuts between 2017 and 2022 that resulted in payment for tests used to screen and diagnose diabetes, heart disease, and other chronic conditions to be cut by 27 percent. Some tests could see a cumulative cut of up to 41 percent.”
Furthermore, reimbursement cuts stifle investment in future generations of diagnostic tests.
The bipartisan and bicameral legislation plans to adjust the existing 2014 Protecting Access to Medicare Act (PAMA). As many may know the PAMA Act, has resulted in “significant cuts to Medicare payments for routine laboratory tests that guide clinical decision-making.” By building a robust clinical laboratory infrastructure, healthcare will be able to reinforce the execution of everyday patient care. This structure, if properly maintained, can provide protection against the inevitable future public health crisis. The Saving Access to Laboratory Service Act would support existing needs while creating innovation for future generations of clinical diagnostics.
In an online press release, Susan Van Meter, ACLA President, commented that “Without congressional intervention this year, laboratories across the country will face a fourth round of Medicare reimbursement cuts, which could threaten the delivery of routine care, undermine the clinical laboratory infrastructure needed to manage multiple public health challenges, and reduce investment in innovation, Congress has acted three times to delay these harmful reimbursement cuts, but long-term reform is needed to safeguard access to the essential tests that patients need.”
The act was put forward early this summer in June by senators Sherrod Brown (D-OH) and Richard Burr (R-NC), along with Reps. Bill Pascrell (D-NJ), Scott Peters (D-CA), Richard Hudson (R-NC), Gus Bilirakis (R-FL), and Kurt Schrader (D-OR). The act would break down the data reporting and offer a simplified process. Policies within the act guide the Centers for Medicare & Medicaid Services (CMS) to gather data from a statistical sampling of not just a few types of labs but all significant types of labs including hospital, independent, and physician office laboratories.
The ACLA praised the potential policy, stating “Targeted sampling, as designed by the Saving Access to Laboratory Services Act, is a straightforward solution to collecting representative private market data to achieve accurate and sustainable Medicare rates for laboratory services. In the long-term, sustainability for lab reimbursement will support strong clinical laboratory infrastructure to protect public health and innovation in tomorrow’s diagnostics while providing robust access to improve patient health.”
To explore more coding and compliance topics subscribe to our Laboratory Compliance Manager Newsletter. The Laboratory Compliance Manager Newsletter is your monthly gateway to the latest laboratory-specific compliance, coding, and reimbursement news including topics like the clinical laboratory fee schedule, coding changes, the final rules, CLIA-waived tests, PLA code releases, and more. Subscribe today!
Information Source:
https://stoplabcuts.org/
The biggest impacts to clinical documentation integrity (CDI) professionals for the 2026 fiscal year (FY) will not be associated with updates to the ICD-10-CM code
It’s virtually axiomatic that if you’re performing a review of your coding, the review should be done under attorney-client privilege. I have said this before
Please log in to your account to comment on this article.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
